Humane Genomics

Summer 2021Active

A platform to make artificial viruses as cancer therapeutics.

Save

Humane Genomics

Summer 2021Active

A platform to make artificial viruses as cancer therapeutics.

Save

Company details

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

Location

New York City, NY, USA; New York, NY, USA

Founded

Unknown

Request the Humane Genomics report.

Humane Genomics has no report yet. Sign in with your email to request one.